Founded in 2010, Invent Biotechnologies develops spin column-based technologies for protein research, cell fractionation and sample preparation. Its platforms enable rapid isolation of proteins, organelles and cellular subfractions while helping preserve biological characteristics relevant to downstream analysis. The company’s expertise centres on protein extraction, protein trafficking studies, organelle isolation and single nuclei preparation for molecular and cellular research. Its technologies support applications in cell biology, proteomics, plant science, biomarker studies and functional analysis of intracellular processes.
Invent Biotechnologies offers a portfolio of research tools that includes the Minute™ product family for cell fractionation, organelle isolation and protein extraction workflows. The company also provides single nuclei isolation kits, plant-specific sample preparation products and reagents for rapid protein extraction from cultured cells and tissues. These technologies support protein localisation studies, organelle function analysis, intracellular trafficking investigations and sample preparation for downstream genomic and proteomic assays. By streamlining sample preparation and fractionation workflows, the company’s products help researchers obtain material suitable for a wide range of analytical techniques.
Europa Biosite subsidiaries distribute for Invent Biotechnologies in Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, Switzerland and the United Kingdom.
